ID
17900
Description
Study Type: Interventional Study Design: Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment Official Title: Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-Randomized Multi-Center Study Demonstrating the Efficacy of Terminal Complement Inhibition in Patients With Cold Agglutinin Disease Using Eculizumab EudraCT-Nummer 2009-01696697 ClinicalTrials.gov-Identifier NCT01303952 https://clinicaltrials.gov/ct2/show/NCT01303952 Genehmigung durch Frau Ose
Link
https://clinicaltrials.gov/ct2/show/NCT01303952
Keywords
Versions (10)
- 10/7/16 10/7/16 -
- 10/10/16 10/10/16 -
- 10/11/16 10/11/16 -
- 10/17/16 10/17/16 -
- 10/18/16 10/18/16 -
- 10/21/16 10/21/16 -
- 10/23/16 10/23/16 -
- 10/24/16 10/24/16 -
- 10/27/16 10/27/16 -
- 11/2/16 11/2/16 -
Uploaded on
October 7, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.